Selective retinal ganglion cell loss in familial dysautonomia

被引:0
作者
Carlos E. Mendoza-Santiesteban
Thomas R. Hedges III
Lucy Norcliffe-Kaufmann
Felicia Axelrod
Horacio Kaufmann
机构
[1] New York University,Dysautonomia Center, Langone Medical Center
[2] Tufts University School of Medicine,New England Eye Center, Tufts Medical Center
来源
Journal of Neurology | 2014年 / 261卷
关键词
Familial dysautonomia; Riley–Day syndrome; Hereditary optic neuropathy; Optical coherence tomography;
D O I
暂无
中图分类号
学科分类号
摘要
To define the retinal phenotype of subjects with familial dysautonomia (FD). A cross-sectional study was carried out in 90 subjects divided in three groups of 30 each (FD subjects, asymptomatic carriers and controls). The study was developed at the Dysautonomia Center, New York University Medical Center. All subjects underwent spectral domain optical coherence tomography (OCT) and full neuro-ophthalmic examinations. In a subset of affected subjects, visual evoked potentials and microperimetry were also obtained. We compared the retinal nerve fiber layer (RNFL) thickness from OCT between the three groups. OCT showed loss of the RNFL in all FD subjects predominantly in the maculopapillary region (63 % temporally, p < 0.0001; and 21 % nasally, p < 0.005). RNFL loss was greatest in older FD subjects and was associated with decreased visual acuity and color vision, central visual field defects, temporal optic nerve pallor, and delayed visual evoked potentials. Asymptomatic carriers of the FD gene mutation all had thinner RNFL (12 % globally, p < 0.005). OCT and clinical neuro-ophthalmological findings suggest that maculopapillary ganglion cells are primarily affected in FD subjects, leading to a specific optic nerve damage that closely resembles mitochondrial optic neuropathies. This raises the possibility that reduced IKAP levels may affect mitochondrial proteins and their function in the nervous system, particularly in the retina.
引用
收藏
页码:702 / 709
页数:7
相关论文
共 107 条
[21]  
Kaufmann H(1997)Optic neuropathy in familial dysautonomia J Neuroophthalmol 17 101-102
[22]  
Axelrod FB(2010)The neuro-ophthalmology of mitochondrial disease Surv Ophthalmol 55 299-334
[23]  
Iyer K(2003)Toxic optic neuropathy Curr Neurol Neurosci Rep 3 410-414
[24]  
Fish I(2011)Mitochondrial optic neuropathies—disease mechanisms and therapeutic strategies Prog Retin Eye Res 30 81-114
[25]  
Norcliffe-Kaufmann L(2013)Drug-related mitochondrial optic neuropathies J Neuroophthalmol 33 172-178
[26]  
Kaufmann H(2000)Leber’s hereditary optic neuropathy differentially affects smaller axons in the optic nerve Trans Am Ophthalmol Soc 98 223-232
[27]  
Macefield VG(1994)Epidemic optic neuropathy in Cuba. Eye findings Arch Ophthalmol 112 691-699
[28]  
Norcliffe-Kaufmann L(2009)OPA1-associated disorders: phenotypes and pathophysiology Int J Biochem Cell Biol 41 1855-1865
[29]  
Axelrod FB(1997)Epidemic optic and peripheral neuropathy in Cuba: a unique geopolitical public health problem Surv Ophthalmol 41 341-353
[30]  
Kaufmann H(2011)Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations Eye (Lond) 25 596-602